top of page
News
Jun 21, 2022
Washington ups pressure on PBMs with more aggressive FTC policy, congressional ask for GAO study
Pressure is increasing on pharmacy benefit managers as the middlemen come under rising scrutiny from Washington for their role in rising...
Jun 17, 2022
FTC targets insulin, threatening to go after PBM-pharma deals that steer into 'commercial bribery'
The Federal Trade Commission voted unanimously yesterday (5-0) to adopt a new policy specifically targeting rising insulin prices, but...
Jun 16, 2022
Let My Doctors Decide: A VICTORY FOR PATIENTS
The recent decision by the Federal Trade Commission to study the business practices of pharmacy benefit managers (PBMs) is a significant...
Jun 16, 2022
FTC puts drugmakers and PBMs on notice that it will crack down on illegal rebate schemes
In a notable move, the Federal Trade Commission put drugmakers and pharmacy benefit managers on notice that the agency will “ramp up...
Jun 15, 2022
The National Consumers League applauds the FTC’s decision to investigate PBMs
NCL is deeply concerned by the lack of transparency and accountability surrounding pharmacy benefit managers (PBMs). The pervasive power...
Jun 15, 2022
Centene to pay $13.7M to settle PBM allegations in New Mexico
Centene will pay $13.7 million to settle more pharmacy benefit management overpayment allegations in Medicaid, this time in New Mexico....
Jun 9, 2022
The Truth about Pharmacy Benefit Managers
Nobody wants fraud — particularly not in medical care. Accordingly, in 1972, Congress passed the Federal Anti-kickback Statute that...
Jun 7, 2022
U.S. probes how pharmacies set drug prices as costs rise
The U.S. Federal Trade Commission has opened a probe into how big pharmacy benefit managers like CVS Caremark affect pricing and...
Jun 7, 2022
FTC Launches Inquiry Into Prescription Drug Middlemen Industry
Agency to Scrutinize the Impact of Vertically Integrated Pharmacy Benefit Managers on the Access and Affordability of Medicine The...
Jun 7, 2022
FTC to Investigate CVS Caremark and Other Pharmacy-Benefit Managers
The Federal Trade Commission is probing CVS Caremark, CVS 0.94%▲ Express Scripts Inc. and other large pharmacy-benefits managers over...
May 24, 2022
Pharmacy Benefit Managers (PBMs) Harm Pharmacies and Patients Alike
Pharmacists play an essential role in the healthcare delivery system. Each day, their top priority is helping patients access medications...
May 24, 2022
PBM Accountability Project Applauds FTC for Examining the Cost-Increasing Impact of PBMs
The Executive Director of the PBM Accountability Project, Doug H. Dority, submitted public comment to the Federal Trade Commission (FTC)...
May 9, 2022
ICYMI | Grassley Press Release on Senate Commerce Committee Hearing
ICYMI | Grassley’s Leadership Recognized Multiple Times During Commerce Committee Hearing On Prescription Drug Pricing Reform WASHINGTON...
May 6, 2022
Highlights from Senate hearing on pharmacy benefit managers' role in drug prices
A U.S. Senate panel grilled secretive pharmacy benefit managers in a hearing Thursday on how to bring fairness and transparency to U.S....
May 5, 2022
Senators decry lack of 'sunlight' on PBM processes, push for reforms in transparency
Several bipartisan senators are clamoring for more transparency into how pharmacy benefit managers conduct their business, potentially...
May 4, 2022
Understanding where your money goes beyond the pharmacy counter
Where are the mystery costs your pharmacy absorbs and how does it affect your drugs and price? Key stakeholders share their expertise...
May 3, 2022
2021 Janssen Transparency Report
Our responsibility as a leader in the healthcare system is to bring forward actionable ideas, data and insights to help create a...
Apr 26, 2022
Can billionaire celebrity Mark Cuban fix America’s broken health system?
The celebrity investor has teamed up with a soft-spoken radiologist to tackle the USA’s healthcare crisis – and he has drug industry...
Apr 20, 2022
How to protect consumers from PBM greed
The rising cost of health care is a sore point for all consumers and nowhere is it more glaring than at the pharmacy counter. However,...
Apr 20, 2022
UnitedHealth Inflated Drug Costs, Louisiana Attorney General Alleges in Suit
UnitedHealth Group Inc. was accused by Louisiana’s attorney general of inflating prescription drug charges in the state’s Medicaid...
Apr 19, 2022
Hospitals' massive cancer drug markups
The prices that private insurers agree to pay hospitals for cancer drugs are often at least double what the hospital paid to acquire the...
Apr 18, 2022
Howard Dean: It’s time to crack down on the middlemen that inflate the costs of drugs like insulin
U.S. Sen. Raphael Warnock just introduced a bill that would cap Americans’ out-of-pocket spending on insulin at $35 a month. The...
Apr 11, 2022
Rein In Profiteering by Drug-Industry Middlemen
The Federal Trade Commission recently requested public comments on the effect of drug-industry middlemen on drug affordability and...
Mar 30, 2022
A new federal framework to improve patient access and health equity
With its landscape focus on reducing the excess burden of disease in vulnerable populations, the Biden administration has clearly renewed...
bottom of page